English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Pharma & Biotech BioTech (Sci&Research)
Cadrock成功攬獲500萬美元投資,目標指向價值350億美元心髒病市場的診療方案研究
Sep 05, 2018 11:00 HKT
Cadrock成功揽获500万美元投资,目标指向价值350亿美元心脏病市场的诊疗方案研究
Sep 05, 2018 11:00 HKT
NANOBIOTIX half year results for the six months ended June 30, 2018
Sep 05, 2018 00:30 HKT
生物医疗科技行业向好 知临集团或大有可为
Sep 04, 2018 11:49 HKT
生物醫療科技行業向好 知臨集團或大有可為
Sep 04, 2018 11:47 HKT
Cadrock Secures US$5m for Therapy Targeting $35 billion Heart Disease Market
Sep 04, 2018 09:00 HKT
NEGTEC announces Crowdfunding Service promoting Regenerative Medicine
Sep 04, 2018 15:00 HKT
NEGTEC, 재생의료 촉진을 지원하기 위한 가상통화의 크라우드 펀딩 포털 사이트 개설
Sep 03, 2018 15:00 HKT
NEGTEC為了支持促進再生醫療 開設使用虛擬貨幣進行眾籌的門戶網站
Sep 03, 2018 15:00 HKT
NEGTEC为了支持促进再生医疗 开设使用虚拟货币进行众筹的门户网站
Sep 03, 2018 15:00 HKT
Genexi 生物技術加速器。平台MVP發布
Aug 20, 2018 17:00 HKT
Genexi 生物技术加速器。平台MVP发布
Aug 20, 2018 17:00 HKT
Genexi Biotech Accelerator. The Platform MVP Release
Aug 20, 2018 17:00 HKT
Ascletis Successfully Listed on the Main Board of HKEX
Aug 01, 2018 21:02 HKT
中國首個原研全口服丙肝治愈方案上市申請獲受理
Aug 01, 2018 18:37 HKT
中国首个原研全口服丙肝治愈方案上市申请获受理
Aug 01, 2018 18:36 HKT
Ascletis' NDA for Its All-oral HCV Treatment Accepted by CFDA
Aug 01, 2018 18:35 HKT
歌禮原研抗丙肝創新藥戈諾衛成績非凡
Jul 31, 2018 20:32 HKT
歌礼原研抗丙肝创新药戈诺卫成绩非凡
Jul 31, 2018 20:31 HKT
Ascletis-developed Ganovo Acquired Extraordinary Achievement
Jul 31, 2018 20:30 HKT
Next >>
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: